{
    "clinical_study": {
        "@rank": "129425", 
        "arm_group": [
            {
                "arm_group_label": "Supplementation of Magnesium oxide.", 
                "arm_group_type": "Experimental", 
                "description": "Supplementation of magnesium oxide (450 mg up to 3 times daily maximum), aiming at a serum magnesium concentration of >= 1,9 mg/dL)."
            }, 
            {
                "arm_group_label": "No supplementation or minimal dose.", 
                "arm_group_type": "No Intervention", 
                "description": "No supplementation (or a minimal dose to keep serum magnesium concentration \u2265 1.2mg/dL depending on the treating physician)."
            }
        ], 
        "brief_summary": {
            "textblock": "Hypomagnesemia is common early after transplantation, especially in association with\n      calcineurin inhibitors and predicts diabetes after transplantation. Magnesium improves\n      glycemic control and insulin sensitivity in diabetics and insulin resistant subjects without\n      diabetes but this was never evaluated in transplant recipients.\n\n      The aim of the study is to assess whether magnesium improves glycemic control and insulin\n      sensitivity early after transplantation.\n\n      The study is an open label study in which adult hypomagnesemic renal transplant recipients\n      are randomized the first 2 weeks after kidney transplantation to magnesium oxide  or no\n      supplementation.\n\n      The hypothesis is that magnesium supplementation in renal transplant recipients exerts a\n      beneficial effect on glycemia and the development of diabetes after transplantation."
        }, 
        "brief_title": "The Effect of Magnesium on Early Post-transplantation Glucose Metabolism", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": "Glucose Metabolism After Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Renal transplantation recipients\n\n          -  > 18 years of age\n\n          -  Less than 2 weeks post-transplantation\n\n          -  Hypomagnesemia < 1,7 milligram/deciliter on 2 consecutive blood samples (laboratory\n             reference interval 1,7 - 2,55 milligram/deciliter).\n\n        Exclusion Criteria:\n\n          -  Pre-existing diabetes mellitus defined as the intake of anti-diabetic drugs at the\n             time of inclusion\n\n          -  Serum creatinine > 3 milligram/deciliter\n\n          -  Active infection (C reactive protein > 3 milligram/deciliter)\n\n          -  Severe hypomagnesemia (< 1,2 milligram/deciliter)\n\n          -  Hypokalemia (< 3,5 milli-equivalent/liter)\n\n          -  Severe hypocalcemia (< 6,5 milligram/deciliter)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889576", 
            "org_study_id": "IDS BE-02-RG-219"
        }, 
        "intervention": {
            "arm_group_label": "Supplementation of Magnesium oxide.", 
            "intervention_name": "Magnesium Oxide", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": "Magnesium Oxide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "glucose", 
        "lastchanged_date": "June 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ghent", 
                    "country": "Belgium", 
                    "zip": "9000"
                }, 
                "name": "Ghent University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Magnesium Supplements on Early Post-transplantation Glucose Metabolism: a Randomized Controlled Trial.", 
        "overall_official": {
            "affiliation": "Ghent University Hospital", 
            "last_name": "Steven Van Laecke, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Belgium: Federal Agency for Medicinal Products and Health Products"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Fasting glycemia, 3 months after transplantation.", 
            "safety_issue": "No", 
            "time_frame": "3 months after transplantation."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889576"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of diabetes after transplantation the first 3 months after transplantation.", 
                "safety_issue": "No", 
                "time_frame": "3 months after transplantation."
            }, 
            {
                "measure": "Incidence of impaired fasting glucose the first 3 months after transplantation.", 
                "safety_issue": "No", 
                "time_frame": "3 months after transplantation."
            }, 
            {
                "measure": "Insulin sensitivity measured by \"Homeostatic Model assessment (HOMA)\", 3 months after transplantation.", 
                "safety_issue": "No", 
                "time_frame": "3 months after transplantation."
            }
        ], 
        "source": "University Hospital, Ghent", 
        "sponsors": {
            "collaborator": {
                "agency": "Astellas Pharma Inc", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital, Ghent", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}